Home

Depression

Depression, Schizophrenia

Read time: 3 min

Congress highlights

Sleep quality, inflammation and early morning activity: all may influence mental health

Poor sleep is a modifiable risk factor linked to depression, schizophrenia, and chronic physical...

Read time: 3 min

Satellite symposium

Beyond symptom reduction and towards engagement with life

Enhancing engagement with life is a key target of treatment in MDD and extends beyond symptom...

Read time: 2 min

Congress highlights

Perspectives on the future of psychiatry: treatment and training

Prevention, prediction of outcome and precision in therapy emerged as themes at the EPA 2021...

Read time: 2 min

Congress highlights

Depression risk rises with cannabis exposure in the developing brain

Epidemiology suggests long-term cannabis use during adolescence increases risk of later depression...

Read time: 3 min

Congress highlights

Individual vulnerability to mood and stress disorders will be predictable

The dream of personalized medicine in mental health is to prevent disorders in people most at risk...

Read time: 2 min

Congress highlights

Promising biomarkers for predicting, monitoring and measuring treatment response

Imaging, blood and digital biomarkers for mental disorders can be used to predict, monitor and...

Read time: 2 min

Congress highlights

Partial dopamine agonists: wide spectrum of activity and indications

Dopamine partial agonists decrease transmission when there is excess of the neurotransmitter, but...

Read time: 3 min

Congress highlights

Can we predict a chronic course in major depressive disorder?

Major depressive disorder often follows a chronic trajectory that involves comorbid affective and...

Read time: 2 min

What are the implications of childhood trauma for depression and its response to therapy?

Childhood trauma is an important risk factor for major depressive disorder (MDD). It is...

Read time: 2 min

Congress highlights

Reconceptualising treatment-resistant depression as difficult-to-treat depression

Treatment-resistant depression is a concept that needs to be clinically re-defined to encompass a...

Read time: 3 min

Congress highlights

Opportunities to improve global mental health

Actions to improve global mental health include development and use of a common language to...

Read time: 3 min

Congress highlights

One disease or many – the complexity of major depressive disorder

Should we consider major depressive disorder as a single disease entity of a collection of...

Depression, Bipolar

Read time: 3 min

Congress highlights

Identifying and managing major depressive disorder with mixed features

According to Rakesh Jain, one in five people with major depressive disorder (MDD) have at least...

Neurotoriun

Neurotorium is your new point of reference for educational content on psychiatry, neurology, and neuroscience.

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind Greece Continue to Progress in Mind South East Asia Continue to Progress in Mind Middle East & Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Japan RC Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind Sweden Continue to Progress in Mind Finland Continue to Progress in Mind Ukraine Continue to Progress in Mind Belgium & Luxembourg Continue to Progress in Mind Switzerland Continue to Progress in Mind Germany Continue to Progress in Mind Austria

You are leaving Progress in Mind

Continue to

Cancel

Progress in Mind Belux

Accept Cancel

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intended for health care professionals.

All the information included in the Website is related to diseases, investigations and existing or potential treatment options and, therefore, directed to health professionals . The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country